A kind of traditional Chinese medicine composition for treating schizophrenia and mania

Abstract

The invention discloses a traditional Chinese medicine composition for treating schizophrenia and mania, and belongs to the technical field of traditional Chinese medicine compositions. Its composition in parts by weight is: Pinellia 10-15 parts, Gentiana 5-10 parts, Citrus aurantium 5-10 parts, buffalo horn 20-30 parts, Scutellaria baicalensis 5-10 parts, Trichosanthes 20-30 parts , 5-10 parts of Shichangpu, 10-15 parts of white peony root, 25-30 parts of radish seed, 5-10 parts of Dannan star, 5-10 parts of white mustard seed, 5-10 parts of poria cocos, 5-10 parts of tangerine peel, gardenia 5-10 parts, Angelica 5-10 parts, Licorice 5-10 parts, Gastrodia elata 10-15 parts, Suanzaoren 5-10 parts, Ophiopogon japonicus 10-15 parts, Rhubarb 10-15 parts, Ginger 10-15 parts. The traditional Chinese medicine composition has the advantages of fast onset of action, good therapeutic effect, and low risk of pathogenic obesity.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating schizophrenia and mania. Background technique [0002] Schizophrenia is a severe mental illness of unknown etiology, mostly in young adults with slow or subacute onset, clinically manifested as a syndrome with various symptoms, involving obstacles in perception, thinking, emotion, and behavior and incoordination of mental activity. Patients generally have clear consciousness and basically normal intelligence, but some patients may experience cognitive impairment during the course of the disease. The course of the disease is generally protracted, showing recurrent attacks, aggravation or deterioration, and some patients eventually develop decline and mental disability, but some patients can maintain recovery or basically recovery after treatment. [0003] 1. Clinical manifestations [0004...

AI Technical Summary

Problems solved by technology

[0008] (4) Most patients with volition and behavior disorders have decreased or even lack of volition, manifested as reduced activities, solitude, passive behavior, lack of due enthusiasm and initiative, decreased interest in work and study, no concern for the future, and no hope for the future Definitely intend, some patients may have some plans and intentions, but they are rarely executed

[0009] (5) Cognitive dysfunction The incidence of cognitive deficits in patients with schizophrenia is high, and about 85% of patients have cognitive dysfunction, such as information processing and selective attention, working memory, short-term memory and learning, executive function Cognitive deficits

[0018] (3) Can't stop talking

[0020] (5) Easily distracted

[0028] Antipsychotic drugs may cause pathogenic obesity. According to different constitutions, most patients will experience a weight gain of 5%-20%, and a few patients may even experience a weight gain of more than 30%. Pathogenic obesity will not only lead to functional decline in patients , prone to three high-level complications, but also cause psychological burden to patients, which is not conducive to treatment

[0029] In addition, regardless of the treatment of schizophrenia or mania, antipsychotic drugs are more expensive, and may have side effects (such as retching, weakness, etc.), and may need to be used in combination with other drugs, such as risperidone needs to be combined with hydrochloric acid Benheyxol use